HomeMIRM • NASDAQ
add
Mirum Pharmaceuticals Inc
Previous close
$75.99
Day range
$74.26 - $76.87
Year range
$36.86 - $78.10
Market cap
3.73B USD
Avg Volume
820.43K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 127.78M | 64.09% |
Operating expense | 109.35M | 33.55% |
Net income | -5.86M | 76.21% |
Net profit margin | -4.59 | 85.49% |
Earnings per share | -0.12 | 76.92% |
EBITDA | 1.07M | 105.81% |
Effective tax rate | -7.36% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 304.55M | 9.41% |
Total assets | 725.82M | 9.85% |
Total liabilities | 470.67M | 9.01% |
Total equity | 255.16M | — |
Shares outstanding | 50.24M | — |
Price to book | 14.90 | — |
Return on assets | -1.76% | — |
Return on capital | -2.22% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -5.86M | 76.21% |
Cash from operations | 12.04M | 416.59% |
Cash from investing | -6.60M | 90.93% |
Cash from financing | 8.69M | 19.16% |
Net change in cash | 16.36M | 123.58% |
Free cash flow | 20.54M | 384.95% |
About
Founded
2018
Headquarters
Website
Employees
349
